Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Umbilical cord blood microtransplantation improves the prognosis of patients with relapsed/refractory myeloid tumors who are not candidates for intensive therapy: Clinical efficacy and mechanism analysis

Chenxiao Du, Shiqin Luo, Yuhui Zhang, Guangshuai Teng, Yifan Duan, Yan Wang, Yanqi Li, Huiqin Zhang, Yuan Zhou, Yajing Chu, Weiping Yuan, Jie Bai

Blood (2025) 146 (Supplement 1): 7656.

https://doi.org/10.1182/blood-2025-7656

Published: 2025

Journal Articles

Ruxolitinib mitigates interferon-induced autoimmune toxicity: Clinical insights from a 465-patient MPN Cohort Retrospective study

Guangshuai Teng, Yuhui Zhang, Anna Li, Chenxiao Du, Yan Wang, Yanqi Li, Lan Peng, Huiqin Zhang, Yifan Duan, Yuan Zhou, Weiping Yuan, Jie Bai

Blood (2025) 146 (Supplement 1): 2044.

https://doi.org/10.1182/blood-2025-2044

Published: 2025

Journal Articles

Long-term efficacy and safety of ropeginterferon alfa-2b under its hidat regimen for the treatment of polycythemia vera

Blood (2025) 146 (Supplement 1): 2039.

https://doi.org/10.1182/blood-2025-2039

Published: 2025

Journal Articles

Hematopoietic JAK2V617F mutation increases susceptibility to atrial fibrillation via NLRP3 inflammasome activation in macrophages

Guangshuai Teng, Ke Shang, Yuhui Zhang, Yifan Duan, Chenxiao Du, Yan Wang, Yanqi Li, Huiqin Zhang, Xiaojing Wei, Yuan Zhou, Weiping Yuan, Jie Bai

Blood (2025) 146 (Supplement 1): 634.

https://doi.org/10.1182/blood-2025-634

Published: 2025

Journal Articles

Low expression of TMSB10 in bone marrow in MDS patients with T cell large granular lymphocytic proliferation is associated with improved immune tolerance status of T cells and disease prognosis: Clinical data and single-cell sequencing analysis

Chenxiao Du, Shiqin Luo, Yuhui Zhang, Guangshuai Teng, Yifan Duan, Yan Wang, Yanqi Li, Huiqin Zhang, Yuan Zhou, Yajing Chu, Weiping Yuan, Jie Bai

Blood (2025) 146 (Supplement 1): 5020.

https://doi.org/10.1182/blood-2025-5020

Published: 2025

Journal Articles

Incidence, risk factors, and survival impact of secondary myelofibrosis in patients with myeloproliferative neoplasms in the real world: A nested case-control study

Yuhui Zhang, Guangshuai Teng, Yunhan Zhao, Yifan Duan, Ke Shang, Chenxiao Du, Yan Wang, Yanqi Li, Huiqin Zhang, Xiaojing Wei, Zonghong Shao, Yuan Zhou, Weiping Yuan, Jie Bai

Blood (2025) 146 (Supplement 1): 7337.

https://doi.org/10.1182/blood-2025-7337

Published: 2025

Journal Articles

Pharmacological mechanism of action and therapeutic potential of a quantitative and qualitative RBC- and hemoglobin-elevating agent AND017 in the Townes SCD model

Jie Bai, Tian Li, Mingzhe Pan, Min Xiong, Dong Liu, Shaojiang Deng, Gang Huang

Blood (2025) 146 (Supplement 1): 1154.

https://doi.org/10.1182/blood-2025-1154

Published: 2025

Journal Articles

Characterization of Hemophagocytic Lymphohistiocytosis Associated with Myeloid Neoplasms at Single-Cell Resolution

Ke Shang, Guangshuai Teng, Yuhui Zhang, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Xuelian Cheng, Yuan Zhou, Yajing Chu, Weiping Yuan, Jie Bai

Blood (2024) 144 (Supplement 1): 4101.

https://doi.org/10.1182/blood-2024-206981

Published: 2024

Journal Articles

Clinical Characterization of Myeloid Neoplasms Patients with Fanconi Anemia Gene Mutations

Yuhui Zhang, Guangshuai Teng, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Xin Hu, Yunhan Zhao, Yuan Zhou, Weiping Yuan, Jie Bai

Blood (2024) 144 (Supplement 1): 3175.

https://doi.org/10.1182/blood-2024-207513

Published: 2024

Journal Articles

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Wang Ying, Jianxiang Wang, Weihua Zhai, Erlie Jiang

Blood (2024) 144 (Supplement 1): 6054.

https://doi.org/10.1182/blood-2024-202404

Published: 2024

Journal Articles

Hematopoietic JAK2 V617F Mutation Increases Risk for Atrial Fibrillation

Guangshuai Teng, Ke Shang, Yuhui Zhang, Yifan Duan, Chenxiao Du, Yan Wang, Huiqin Zhang, Weiping Yuan, Yuan Zhou, Jie Bai

Blood (2024) 144 (Supplement 1): 5740.

https://doi.org/10.1182/blood-2024-206325

Published: 2024

Journal Articles

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Mouse MDS Model of an Inducible Mutant c-Myc Knock-in

Gang Huang, Jie Bai, Mingzhe Pan, Dong Liu, Min Xiong, Shaojiang Deng

Blood (2024) 144 (Supplement 1): 4140.

https://doi.org/10.1182/blood-2024-207858

Published: 2024

Journal Articles

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Townes SCD Mouse Model

Gang Huang, Jie Bai, Mingzhe Pan, Dong Liu, Min Xiong, Shaojiang Deng

Blood (2024) 144 (Supplement 1): 2488.

https://doi.org/10.1182/blood-2024-208058

Published: 2024

Journal Articles

Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized Trial (TE-ITP study)

Yunfei Chen, Ting Sun, Da Gao, Wei Wang, ZePing Zhou, Guangxun Gao, Yi Wang, Hu Zhou, Yanping Song, Yinghui Lai, Zhenyu Yan, Jinsong Yan, Jie Bai, Lei Zhang

Blood (2024) 144 (Supplement 1): 3937.

https://doi.org/10.1182/blood-2024-202716

Published: 2024

Journal Articles

Chromatin Modifier Hmga1 Maintains Hematopoietic Stem Cell Integrity in Stress Conditions

Jie Bai, Supannika Sorin, Arusyak Ivanyan, Mihoko Iimori, Ai Hamashima, Gang Huang, Kimi Araki, Goro Sashida

Blood (2024) 144 (Supplement 1): 26.

https://doi.org/10.1182/blood-2024-212002

Published: 2024

Journal Articles

Cyclophosphamide, Mitoxantrone Hydrochloride Liposome, Vincristine, and Prednisone Regimen with or without Rituximab (CMOP±R) Shows High Efficacy As a First-Line Treatment for Non-Hodgkin's Lymphoma: A Phase II Clinical Trial with Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis

Tao You, Jingxian Gu, Peng Xu, Jiebing Xiao, Huiru Cao, Wei Dai, Jie Bai, Peng Wang, Xiao Ma, Depei Wu, Haiwen Huang

Blood (2024) 144 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2024-204404

Published: 2024

Journal Articles

Remarkable Molecular Response in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b

Blood (2024) 144 (Supplement 1): 4562.

https://doi.org/10.1182/blood-2024-203148

Published: 2024

Journal Articles

Trisomy 8 Remodels Chromatin and Activates Transcription of Runx1-Target Genes in Hematopoietic Stem Cell

Jie Bai, Kimi Araki, Yasuhiro Kazuki, Sho Kubota, Kenta Kikuchi, Ai Hamashima, Mihoko Iimori, Supannika Sorin, Minetaro Ogawa, Daisuke Kurotaki, Mitsuo Oshimura, Goro Sashida

Blood (2023) 142 (Supplement 1): 951.

https://doi.org/10.1182/blood-2023-179728

Published: 2023

Journal Articles

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Weihua Zhai, Shulian Chen, Xiaoyu Zhang, Yi He, Sizhou Feng, Mingzhe Han, Xingli Zhao, Jie Bai, Lijuan Li, Zhihua Zhang, Ying Wang, Erlie Jiang, Jianxiang Wang

Blood (2023) 142 (Supplement 1): 7073.

https://doi.org/10.1182/blood-2023-180077

Published: 2023

Journal Articles

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Wei Liu, Rongfu Zhou, Panjing Wang, Hu Zhou, Jie Bai, Xianghua Wang, Yueshen Ma, Zhen Song, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Feng Xue, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2023-174587

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Umbilical cord blood microtransplantation improves the prognosis of patients with relapsed/refractory myeloid tumors who are not candidates for intensive therapy: Clinical efficacy and mechanism analysis

Ruxolitinib mitigates interferon-induced autoimmune toxicity: Clinical insights from a 465-patient MPN Cohort Retrospective study

Long-term efficacy and safety of ropeginterferon alfa-2b under its hidat regimen for the treatment of polycythemia vera

Hematopoietic JAK2V617F mutation increases susceptibility to atrial fibrillation via NLRP3 inflammasome activation in macrophages

Low expression of TMSB10 in bone marrow in MDS patients with T cell large granular lymphocytic proliferation is associated with improved immune tolerance status of T cells and disease prognosis: Clinical data and single-cell sequencing analysis

Incidence, risk factors, and survival impact of secondary myelofibrosis in patients with myeloproliferative neoplasms in the real world: A nested case-control study

Pharmacological mechanism of action and therapeutic potential of a quantitative and qualitative RBC- and hemoglobin-elevating agent AND017 in the Townes SCD model

Characterization of Hemophagocytic Lymphohistiocytosis Associated with Myeloid Neoplasms at Single-Cell Resolution

Clinical Characterization of Myeloid Neoplasms Patients with Fanconi Anemia Gene Mutations

Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for ASCT in Patients with Low- or Intermediate-Risk AML

Hematopoietic JAK2 V617F Mutation Increases Risk for Atrial Fibrillation

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in a Mouse MDS Model of an Inducible Mutant c-Myc Knock-in

Pharmacological Evaluation of a First-in-Class Hemoglobin Elevating Agent (HbEA) AND017 in Townes SCD Mouse Model

Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized Trial (TE-ITP study)

Chromatin Modifier Hmga1 Maintains Hematopoietic Stem Cell Integrity in Stress Conditions

Cyclophosphamide, Mitoxantrone Hydrochloride Liposome, Vincristine, and Prednisone Regimen with or without Rituximab (CMOP±R) Shows High Efficacy As a First-Line Treatment for Non-Hodgkin's Lymphoma: A Phase II Clinical Trial with Matching-Adjusted Indirect Treatment Comparison (MAIC) Analysis

Remarkable Molecular Response in Patients with Polycythemia Vera Treated with Ropeginterferon Alfa-2b

Trisomy 8 Remodels Chromatin and Activates Transcription of Runx1-Target Genes in Hematopoietic Stem Cell

The Efficacy of Modified Melphalan and Busulfan-Based Conditioning Regimen for Autologous-HSCT in Low-Risk and Intermediate-Risk AML Patients

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only